ipilimumab
bms
['melanoma', 'ipilimumab']
more from #esmo22: investigational til therapy shows 50% reduction in pfs measures over ipilimumab in phase 3 study in unresectable #melanoma. read more: 
CGTLive™ delivers quality and relevant information to healthcare professionals on cell, gene, regenerative, and engineered medicines to ultimately improve care.